Construction of a Prefabricated Modular Building for a Thermal Disinfection and Decontamination Station for Pathogenicity Groups III–IV Effluents

As part of an unscheduled inspection mandated by the Ministry of Industry and Trade of the Russian Federation (Order No. 589), INEX specialists were invited to participate in the CAPA (Corrective and Preventive Actions) audit of the Biolife NIRC LLC facilities.

The audit was conducted by the State Institute of Drugs and Good Practices (SID & GP). The CAPA methodology is a critical component of Quality Management Systems, focused on monitoring operational systems, identifying potential non-conformities, and developing a corrective plan to mitigate risks before they impact product safety.

Collaborative Expertise & Risk Mitigation: In response to the audit findings, INEX engaged in a series of strategic consultations with Biolife’s technical team and leading experts from the Chumakov Institute of Poliomyelitis and Viral Encephalitides. This high-level collaboration ensured that the laboratory's infrastructure aligns with the most rigorous biopharmaceutical standards.

Key outcomes of the CAPA monitoring included:

• Identification of Potential Risks: Thorough analysis of existing workflows to detect and eliminate any non-compliance with GMP and safety regulations.

• Architectural Layout Refinement: INEX specialists revised the planning solutions for the new microbiology laboratory to optimize personnel and material flows.

• Engineering Documentation Adjustment: Updated project documentation to incorporate enhanced technological requirements, ensuring higher efficiency and accuracy in laboratory research.

Setting Industry Standards: Biolife NIRC is a market leader in certifying the safety of pharmaceuticals, medical equipment, and in-vitro diagnostics. By integrating the results of the CAPA audit into the facility design, INEX has helped establish a new benchmark for technological excellence and operational reliability in the industry.